Indicator Details: Total Estimated and Projected U.S. Population in Millions by Race/Ethnicity
Data Sources
 
Stratification and Year Choices:

  Source
  • U.S. Census

  View Data By:
  Chart Format


+ View Data Table




Although the numbers in all race/ethnicity groups are expected to continue growing between 2010 and 2050, the number of persons of non-Hispanic black (38 to 61 million), Asian (14 to 33 million), and, especially, Hispanic white (50 to 92 million) race/ethnicity, are expected to grow much faster than the number of persons of non-Hispanic white race/ethnicity (197 to 210 million).

The U.S. population was 309 million in 2010; by 2050, the U.S. population is estimated to be greater than 400 million persons.
Chart Explanation: According to the U.S. Census, the total U.S. population in 2010 was 308,745,538; by 2050, the population is expected to be 419,853,587. While the populations of white, black, Asian, and other (including two or more races) races are all expected to grow over time, the rates of growth are expected to be much higher in the black (37.7 to 61.4 million), Hispanic (50.5 to 92.3 million), and Asian (14.5 to 33.4 million) populations, relative to the non-Hispanic white population (196.8 to 210.3 million).
CKD is more common is some racial and ethnic subgroups. Additionally, progression to ESRD is more common among blacks (who account for 29% of the ESRD population, compared to 12% of the general population) (United States Renal Data System, 2011) and white Hispanics (Peralta et al., 2006); however, the risk of mortality is lower in these subgroups. Thus, race/ethnicity could be considered a risk factor (albeit non-modifiable) for both initiation and progression of CKD. It is important for a U.S. CKD surveillance system to estimate the proportions of the population that will fall into these higher-risk categories as the population changes over time. The U.S. Census Bureau (www.census.gov) conducts a population census every 10 years, as mandated by the U.S. Constitution to guide apportionment of seats in the U.S. House of Representatives. Census 2000 and Census 2010 contained items regarding age, gender, race, Hispanic/Latino origin, and housing characteristics and was administered to the entire resident population of the United States. From the data collected, both population estimates (www.factfinder2.com) and projections (United States Census Bureau, 2008; http://www.census.gov/population/www/projections/index.html) are available publicly.

CKD is more common is some racial and ethnic subgroups. Additionally, progression to ESRD is more common among blacks (who account for 29% of the ESRD population, compared to 12% of the general population) (United States Renal Data System, 2011) and white Hispanics (Peralta et al., 2006); however, the risk of mortality is lower in these subgroups. Thus, race/ethnicity could be considered a risk factor (albeit non-modifiable) for both initiation and progression of CKD. It is important for a U.S. CKD surveillance system to estimate the proportions of the population that will fall into these higher-risk categories as the population changes over time. The U.S. Census Bureau (www.census.gov) conducts a population census every 10 years, as mandated by the U.S. Constitution to guide apportionment of seats in the U.S. House of Representatives. Census 2000 and Census 2010 contained items regarding age, gender, race, Hispanic/Latino origin, and housing characteristics and was administered to the entire resident population of the United States. From the data collected, both population estimates (www.factfinder2.com) and projections (United States Census Bureau, 2008; http://www.census.gov/population/www/projections/index.html) are available publicly.
FieldData
Description of MeasureRace/ethnicity in the general population
Data SourceUnited States Census
Type of Data SourcePublic
Data SetU.S. estimates/projections 2000-2050
Health Care System DataNo
Regional or National?National
Demographic GroupAll U.S. residents
NumeratorNumber of U.S. residents of particular race/ethnicity
DenominatorNumber of all U.S. residents
Primary Data Source IndicatorRace/ethnicity
Primary Indicator Method of MeasurementQuestionnaire (census-taking)
Secondary (1) VariableAge
Secondary (1) Indicator Method of MeasurementQuestionnaire (census-taking)
Secondary (2) VariableGender
Secondary (2) Indicator Method of MeasurementQuestionnaire (census-taking)
Frequency of Measurement (Primary)Every 10 years (cross-sectional)
U.S. Region Covered by Primary VariableAll
Period Currently Available2050
Pending Data2010 projections; 2020 estimates
Additional Data Items of InterestProjections of U.S. population by demographic group through 2050
Limitations of IndicatorSelf-reported race/ethnicity; projections associated with some amount of error
Analytic ConsiderationsRace/ethnicity must be examined separately; age groups/gender can be collapsed to get total numbers
References and Sources:
  • National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD: National Institutes of Health; 2011.
    https://www.usrds.org/reference.aspx
  • Peralta CA, Shlipak MG, Fan D, et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2892-9.
    http://www.ncbi.nlm.nih.gov/pubmed/16959827
  • Hollmann FW, Mulder TJ, Kallan JE. Population Division, U.S. Census Bureau. Methodology and Assumptions for the Population Projections of the United States: 1999 to 2100. Population Division Working Paper No. 38; January 2000.
    http://www.census.gov/population/www/documentation/twps0038.pdf
Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd